Barrett’s esophageal cancer: endoscopic diagnosis and treatment

Barrett’s esophagus, being a precancerous disease, increases the risks of adenocarcinoma development by several dozen times. In recent years, there has been an increase in the incidence of esophageal adenocarcinoma in a number of countries, which makes the problem of timely diagnosis of early neoplastic changes in the epithelium against the background of Barrett’s esophagus especially relevant. In the endoscopy department of the P. A. Herzen Moscow Oncology Research Institute, 760 patients were examined in 2012-2024, in whom Barrett’s esophagus was detected during upper GI endoscopy. The disease was detected in men 2 times more often than in women (526 vs 254). In more than half of the patients, we observed a long segment of BE metaplasia (55.3% [95% CI: 51.7%-58.8%]). Different types of epithelial neoplasia were detected in 177 examined patients, which accounted for 23% of the total number of patients with BE. It was found that the greatest number of be changes were detected within a long segment of metaplasia (74.5% [95% CI: 68.1%-80.9%]). In less than 24% of cases [95% CI: 17.4%-30.0%], lesions were found within the short segment of BE. Some patients (85.7%) underwent endoscopic removal of neoplasms, which was considered radical based on the results of a pathomorphological examination of surgical material. We identified several signs characteristic of mild and severe epithelial dysplasia, as well as non-invasive Barrett’s esophageal adenocarcinoma. We also described treatment strategies in case of detecting superficial neoplasms.

Barrett’s esophagus, esophageal adenocarcinoma, Prague criteria, narrow-band imaging, endoscopic treatment

1. Spechler S. J., Souza R. F. Barrett’s esophagus. N Engl J Med. 2014 Aug 28;371(9):836-45. doi: 10.1056/NEJMra1314704.

2. Cook M. B., Coburn S. B., Lam J. R. et аl. Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort. Gut. 2018 Mar;67(3):418-529. doi: 10.1136/gutjnl-2016-312223.

3. Huang J., Wang M., Li Z. et al. IDDF2024-ABS-0424 Global incidence of oesophageal cancer by histological and anatomical subtypes: a systematic analysis. Gut. 2024;73: A378-A379 doi: 10.1136/gutjnl-2024-IDDF.337.

4. Beydoun A. S., Stabenau K. A., Altman K. W., Johnston N. Cancer Risk in Barrett’s Esophagus: A Clinical Review.Int J Mol Sci. 2023 Mar 23;24(7):6018. doi: 10.3390/ijms24076018.

5. Weusten B. L.A.M., Bisschops R., Dinis-Ribeiro M. et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440.

6. Rajendra S. Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 Nov 1;117(11):1880. doi: 10.14309/ajg.0000000000001896.

7. Rubenstein J. H., Sawas T., Wani S. et al. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia. Gastroenterology. 2024 Jun;166(6):1020-1055. doi: 10.1053/j.gastro.2024.03.019.

8. Qumseya B., Sultan S., Bain P. et al. ASGE Standards of Practice Committee Chair. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019 Sep;90(3):335-359.e2. doi: 10.1016/j.gie.2019.05.012.

9. Gupta N., Gaddam S., Wani S. B. et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc. 2012 Sep;76(3):531-8. doi: 10.1016/j.gie.2012.04.470.

10. Sharma P., Hawes R. H., Bansal A. et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut. 2013 Jan;62(1):15-21. doi: 10.1136/gutjnl-2011-300962.

11. de Groof A. J., Fockens K. N., Struyvenberg M. R. et al. Blue-light imaging and linked-color imaging improve visualization of Barrett’s neoplasia by nonexpert endoscopists. Gastrointest Endosc. 2020 May;91(5):1050-1057. doi: 10.1016/j.gie.2019.12.037.

12. Everson M. A., Lovat L. B., Graham D. G. et al. Virtual chromoendoscopy by using optical enhancement improves the detection of Barrett’s esophagus-associated neoplasia. Gastrointest Endosc. 2019 Feb;89(2):247-256.e4. doi: 10.1016/j.gie.2018.09.032.

13. Sharma P., Dent J., Armstrong D. et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006 Nov;131(5):1392-9. doi: 10.1053/j.gastro.2006.08.032.

14. Clermont M., Falk G. W. Clinical Guidelines Update on the Diagnosis and Management of Barrett’s Esophagus. Dig Dis Sci. 2018 Aug;63(8):2122-2128. doi: 10.1007/s10620-018-5070-z.

15. Hamade N., Vennelaganti S., Parasa S. et al. Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett’s Esophagus to Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol. 2019 Apr;17(5):864-868. doi: 10.1016/j.cgh.2018.07.008.

16. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003 Dec;58(6 Suppl): S3-43. doi: 10.1016/s0016-5107(03)02159-x.

17. Sharma P., Bergman J. J., Goda K. et al. Development and Validation of a Classification System to Identify High-Grade Dysplasia and Esophageal Adenocarcinoma in Barrett’s Esophagus Using Narrow-Band Imaging. Gastroenterology. 2016 Mar;150(3):591-8. doi: 10.1053/j.gastro.2015.11.037.

18. Goda K., Takeuchi M., Ishihara R. et al. Diagnostic utility of a novel magnifying endoscopic classification system for superficial Barrett’s esophagus-related neoplasms: a nationwide multicenter study. Esophagus. 2021 Oct;18(4):713-723. doi: 10.1007/s10388-021-00841-1.

19. He T., Iyer K. G., Lai M. et al. Endoscopic features of low-grade dysplastic Barrett’s. Endosc Int Open. 2023 Aug 7;11(8): E736-E742. doi: 10.1055/a-2102-7726.

20. Tsoi E. H., Fehily S., Williams R. et al. Diffuse endoscopically visible, predominantly low-grade dysplasia in Barrett’s esophagus (with video). Endosc Int Open. 2019 Dec;7(12): E1742-E1747. doi: 10.1055/a-1031-9327.

21. van der Wel M. J., Coleman H. G., Bergman J. J.G.H.M. et al. BOLERO working group. Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett’s dysplasia using digital pathology. Gut. 2020 May;69(5):811-822. doi: 10.1136/gutjnl-2019-318985.

22. Yoshida N., Doyama H., Nakanishi H. et al. White globe appearance is a novel specific endoscopic marker for gastric cancer: A prospective study. Dig Endosc. 2016 Jan;28(1):59-66. doi: 10.1111/den.12519.

23. Kubota Y., Tanabe S., Harada Y. et al. Barrett’s Esophageal Adenocarcinoma Involving a White Globe Appearance within the Long-Segment Barrett’s Esophagus. Case Rep Gastroenterol. 2020 Oct 22;14(3):510-515. doi: 10.1159/000508861.

24. Ivashkin V. T., Mayev I. V., Kaprin A. D. et al. Early Detection of Oncological Diseases of the Digestive System (Guidelines of the Russian Gastroenterological Association and the Russian Association of Oncologists for Primary Care Physicians).Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(5):53-74. (In Russ.) doi: 10.22416/1382-4376-2019-29-5-53-74.@@ Ивашкин В. Т., Маев И. В., Каприн А. Д. и соавт. Раннее выявление онкологических заболеваний органов пищеварения (методическое руководство Российской гастроэнтерологической ассоциации и Ассоциации онкологов России для врачей первичного звена здравоохранения). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2019;29(5):53-74. doi: 10.22416/1382-4376-2019-29-5-53-74.

25. Weusten B. L.A.M., Bisschops R., Dinis-Ribeiro M. et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2023 Dec;55(12):1124-1146. doi: 10.1055/a-2176-2440.

26. Rubenstein J. H., Sawas T., Wani S. et al. AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett’s Esophagus and Related Neoplasia. Gastroenterology. 2024 Jun;166(6):1020-1055. doi: 10.1053/j.gastro.2024.03.019.

27. Wani S., Qumseya B., Sultan S. et al. Endoscopic eradication therapy for patients with Barrett’s esophagus-associated dysplasia and intramucosal cancer. Gastrointest Endosc. 2018 Apr;87(4):907-931.e9. doi: 10.1016/j.gie.2017.10.011.

28. Rajendra S. Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline. Am J Gastroenterol. 2022 Nov 1;117(11):1880. doi: 10.14309/ajg.0000000000001896.